Concepedia

Publication | Closed Access

Evaluation of aprepitant and fosaprepitant in pediatric patients

DOI

12

Citations

17

References

2019

Year

Yoshimasa Saito, Tadashi Kumamoto, Takamichi Arima, Nami Shirakawa, S Ishimaru, Tomoko Sonoda, Miho Nakajima, Masanaka Sugiyama, Ayumu Arakawa, Hironobu Hashimoto,
Pediatrics International

Abstract

Aprepitant and fosaprepitant were safely used and may be equally useful for pediatric patients receiving highly emetogenic chemotherapy. CR rate may be associated with patient age.

References

YearCitations

Page 1